Akero Therapeutics Inc buy Cantor Fitzgerald
Start price
19.09.23
/
50%
€48.20
Target price
19.09.24
€64.47
Performance (%)
-48.36%
End price
20.09.24
€24.89
Summary
This prediction ended on 20.09.24 with a price of €24.89. The BUY prediction by Cantor_Fitzgerald for Akero Therapeutics Inc performed very badly with a performance of -48.36%. Cantor_Fitzgerald has a follow-up prediction for Akero Therapeutics Inc where he still thinks Akero Therapeutics Inc is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Akero Therapeutics Inc | 1.660% | 1.660% | -42.072% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $69.00 price target on the stock.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€13.80
11.10.23
11.10.23
€36.75
11.10.24
11.10.24
86.38%
04.10.24
04.10.24
Stopped prediction by Cantor_Fitzgerald for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€20.34
20.06.24
20.06.24
-
20.06.25
20.06.25
26.45%
04.10.24
04.10.24
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€43.60
04.10.23
04.10.23
€65.81
04.10.24
04.10.24
-42.11%
02:15
02:15